Posts

Showing posts from November, 2022

Hemoglobin in Pancreatic Cancer – short report, ISSN 2753-8176 (online), DOI: 10.13140/RG.2.2.20722.79043

Image
Hemoglobin in Pancreatic Cancer – short report, ISSN 2753-8176 (online), DOI: 10.13140/RG.2.2.20722.79043 A na Pedro (1) 1. Gwyntwr1386 Pharmacy, Regus Chester Business Park, Heronsway,Chester CH4 9QR, United Kingdom anapedrolaboratories@gmail.com S ome cancer cell types such as from prostate, lung and breast cancers might express hemoglobin beta , which might be a defense mechanism of tumor cells against intracellular reactive oxygen species (ROS) (1). We examine the presence of hemoglobin subunits in different types of pancreatic adenocarcinoma cell lines cell culture conditioned media (CM)(https://zenodo.org/record/7339463#.Y3pC5XbP3IU). The most common of pancreatic cancer (PC) is adenocarcinoma, accounting for about 90% of cases. Around 1–2% of cases of PC have a neuroendocrine origin , arising from the hormone-producing cells of the pancreas. These tumours in general are less aggressive than pancreatic adenocarcinoma. PanIN (pancreatic intraepithelial neoplasia, a histo...